Roche Buys Shares In Tender Offer For Anadys Pharmaceuticals
23 Novembre 2011 - 7:39AM
Dow Jones News
Roche Holding AG (ROG.VX) Wednesday said its subsidiary Bryce
Acquisition Corporation accepted for payment all shares tendered
pursuant to its offer for all outstanding shares of Anadys
Pharmaceuticals, Inc. (ANDS) at $3.70 per share in cash.
MAIN FACTS:
- As of the expiration of the tender offer, a total of
approximately 54,532,568 shares of Anadys common stock were
tendered and not withdrawn (including approximately 2,345,764
shares tendered by delivery of notices of guaranteed delivery),
representing approximately 94% of Anadys's outstanding shares.
- Roche intends to complete the acquisition of Anadys through a
short-form merger without a vote or meeting of Anadys's
shareholders.
- In the merger, all shares of Anadys not owned by Anadys, Roche
or their respective wholly owned subsidiaries (other than shares as
to which appraisal rights are validly exercised) will be converted
into the right to receive the same cash consideration per share as
was paid in the tender offer.
-Zurich Bureau, Dow Jones Newswires, +41 43 443 80 47;
zurichdjnews@dowjones.com
Grafico Azioni Anadys (NASDAQ:ANDS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Anadys (NASDAQ:ANDS)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Anadys Pharmaceuticals (MM) (NASDAQ): 0 articoli recenti
Più Anadys Pharmaceuticals Inc. Articoli Notizie